12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks
Clinical trial NCT02303626 · COMPLETED
Trial details
- NCT number
- NCT02303626
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2016-01-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.